Efficacy and safety of perioperative FLOT (5-FU, LV, oxaliplatin, docetaxel) chemotherapy in gastric and gastroesophageal junction adenocarcinoma: Real-life data from Turkish oncology group

Erol, C.Basoglu, T.Sakin, A.Ozden, E.Cubuk, D.Yumuk, P. F.Dogan, M.2024-02-232024-02-2320210923-75341569-8041https://doi.org/10.1016/j.annonc.2021.08.1514https://hdl.handle.net/20.500.12452/11579Congress of the European-Society-for-Medical-Oncology (ESMO) -- SEP 16-21, 2021 -- ELECTR NETWORK[Abstract Not Availabe]eninfo:eu-repo/semantics/openAccess[Keyword Not Available]Efficacy and safety of perioperative FLOT (5-FU, LV, oxaliplatin, docetaxel) chemotherapy in gastric and gastroesophageal junction adenocarcinoma: Real-life data from Turkish oncology groupConference Object32S1058S1058Q1WOS:000700527702418Q110.1016/j.annonc.2021.08.1514